Post-Transplant Malignancy (Lymphoma) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Post-Transplant Malignancy (Lymphoma)
Post-transplant malignancy lymphoma (PTLD) is a serious but treatable condition that can arise after an organ or stem cell transplant. It’s a type of cancer linked to the immunosuppressive medications necessary to prevent organ rejection. Facing a PTLD diagnosis can be overwhelming, especially due to high treatment costs. TheDrugClub helps lighten this financial burden, offering significant savings on essential prescriptions for patients and their families.
What is Post-Transplant Malignancy Lymphoma (PTLD)?
Post-transplant malignancy lymphoma, or PTLD, is a serious complication that can develop in individuals who have undergone an organ or stem cell transplant. To prevent their body from rejecting the new organ or cells, transplant recipients must take immunosuppressive medications for life. While these drugs are vital, they also weaken the immune system, making it less able to fight off infections and abnormal cells. This reduced immune surveillance can, in some
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.